Cardiol Therapeutics (CRDL)
(Delayed Data from NSDQ)
$2.41 USD
+0.05 (2.12%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $2.40 -0.01 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Cardiol Therapeutics Inc. [CRDL]
Reports for Purchase
Showing records 1 - 2 ( 2 total )
Company: Cardiol Therapeutics Inc.
Industry: Medical - Drugs
ARCHER Presentation on the World Stage is Evidence of High-Level Interest in CardiolRx; Reit Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Cardiol Therapeutics Inc.
Industry: Medical - Drugs
CardiolRx Poised for the Final Stretch; Initiating With a Buy Rating and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
|